Image Source: Pexels
Eli Lilly CEO David Ricks joins ‘Squawk Box’ to discuss the company’s quarterly earnings results, which reported third-quarter adjusted profit and revenue that missed expectations, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, why the company is slashing its full-year adjusted profit guidance, and more.Video Length: 00:07:13More By This Author:McDonald’s Beats On Profit And Revenue, Reverses U.S. Same-Store Sales Declines
Lockheed Martin Reports EPS Beat, Revenue Miss
United Airlines CEO Scott Kirby On Q3 Results, Impact Of Boeing Strike And Route Expansion
